Harriet Kluger, MD

Professor of Medicine (Medical Oncology); Director, Yale SPORE in Skin Cancer, Yale Cancer Center; Director, , Yale Immuno-Oncology Training Program; Associate Cancer Center Director for Education, Training and Faculty Development, Yale Cancer Center; Deputy Section Chief, Medical Oncology

Departments & Organizations

Internal Medicine: Medical Oncology: Subset Medical Oncology Faculty

Discovery to Cure Internship

SPORE in Skin Cancer

WHRY Pilot Project Program Investigators

Yale Cancer Center: Developmental Therapeutics | K12 Calabresi Immuno-Oncology Training Program (IOTP) | Melanoma Program | Prostate & Urologic Cancers Program

Yale Medicine

Office of Cooperative Research


Dr. Kluger is a medical oncologist who sees patients with melanoma and renal cell carcinoma. Her research interests focus on developing new drug regimens and biomarkers predictive of response to therapies in melanoma and renal cell carcinoma. She participates in a number of clinical trials studying new agents for the treatment of these diseases, both targeting the immune system and the cancer cell. She runs an active research laboratory that studies tumor and immune cells from patients treated with novel therapies to determine mechanisms of resistance to therapy and mediators of toxicity from immune checkpoint inhibitors. The laboratory also conducts pre-clinical studies to improve treatment regimens for patients with melanoma, renal cell carcinoma or brain metastasis.

Education & Training

MD Tel Aviv University (1993)
Fellow Yale University School of Medicine
Resident University of New Mexico
Board Certification AB of Internal Medicine, Medical Oncology (2002, recertified: 2012)

Edit this profile

Contact Info

Harriet Kluger, MD
Patient Care Location
Yale Cancer CenterYale New Haven Hospital
20 York Street, Ste North Pavilion 4

New Haven, CT 06510
View on map...
Mailing Address
Medical OncologyPO Box 208032
New Haven, CT 06520-8028